245 related articles for article (PubMed ID: 36422511)
21. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China.
Tung TH; Lin XQ; Chen Y; Zhang MX; Zhu JS
Expert Rev Vaccines; 2022 Feb; 21(2):261-267. PubMed ID: 34894991
[TBL] [Abstract][Full Text] [Related]
22. Relationship between attitudes toward the effectiveness of vaccine, concerns about adverse reactions, and proactively taking SARS-Cov-2 vaccine for family among medical workers in Taizhou, China.
Luo C; Zhang MX; Shi GF; Chen HX; Tung TH
Expert Rev Vaccines; 2022 Feb; 21(2):269-275. PubMed ID: 34875964
[TBL] [Abstract][Full Text] [Related]
23. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
Front Immunol; 2022; 13():863554. PubMed ID: 35711445
[TBL] [Abstract][Full Text] [Related]
24. Assessment of adverse events among healthcare workers following the Janssen COVID-19 vaccine in Tigray, Ethiopia.
Abera BT; Teka H; Berhe E; Gebru MA; Zenebe D; Abraha HE; Hailu A
Sci Rep; 2024 Feb; 14(1):3255. PubMed ID: 38332047
[TBL] [Abstract][Full Text] [Related]
25. Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
Maruyama A; Sawa T; Teramukai S; Katoh N
J Infect Chemother; 2022 Jul; 28(7):934-942. PubMed ID: 35361536
[TBL] [Abstract][Full Text] [Related]
26. Factors Influencing the Healthcare Workers' Willingness to Receive the COVID-19 Booster Dose in Tuscany (Italy).
Guarducci G; Mereu G; Golinelli D; Galletti G; Gemmi F; Cartocci A; Holczer N; Bacci L; Sergi A; Messina G; Mari V; Nante N
Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140156
[TBL] [Abstract][Full Text] [Related]
27. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China.
Zhang MX; Zhang TT; Shi GF; Cheng FM; Zheng YM; Tung TH; Chen HX
Expert Rev Vaccines; 2021 Jul; 20(7):891-898. PubMed ID: 33929930
[No Abstract] [Full Text] [Related]
28. The second dose of COVID-19 vaccine booster hesitancy among health care workers in China: A multicenter cross-sectional study.
Zhang L; Wu Y; Jing S; Liu X; Ren T; Liu X; Dai Z; Fu J; Chen X; Xiao W; Huang Y; Wang H; Wang W; Gu X; Ma L; Zhang S; Yu Y; Li L; Su X; Qiao Y
Am J Infect Control; 2024 May; 52(5):525-532. PubMed ID: 38007100
[TBL] [Abstract][Full Text] [Related]
29. Multi-dimensional psychosocial factors influencing the willingness to receive a COVID-19 vaccine booster: A survey among the public in Mainland China.
Lin Y; Huang Z; Xu X; Du W; Alias H; Hu Z; Wong LP
Hum Vaccin Immunother; 2022 Nov; 18(6):2126667. PubMed ID: 36165498
[TBL] [Abstract][Full Text] [Related]
30. Acceptance and willingness to pay under the different COVID-19 vaccines: A contingent valuation method.
Prasert V; Thavorncharoensap M; Vatcharavongvan P
Res Social Adm Pharm; 2022 Nov; 18(11):3911-3919. PubMed ID: 35691798
[TBL] [Abstract][Full Text] [Related]
31. An Analysis of the Willingness to the COVID-19 Vaccine Booster Shots among Urban Employees: Evidence from a Megacity H in Eastern China.
Hu T; Li L; Lin C; Yang Z; Chow C; Lu Z; You C
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206495
[TBL] [Abstract][Full Text] [Related]
32. Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China.
Shao H; Lin XQ; Chen Y; Lv L; Ying CQ; Tung TH; Zhu JS
Hum Vaccin Immunother; 2023 Dec; 19(1):2158012. PubMed ID: 36606519
[TBL] [Abstract][Full Text] [Related]
33. Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: a cross-sectional study on the guardians of children in China.
Ma L; Yang J; Zhang T; Han X; Huang Q; Yang Y; Feng L; Yang W; Wang C
Hum Vaccin Immunother; 2022 Nov; 18(5):2049169. PubMed ID: 35417663
[TBL] [Abstract][Full Text] [Related]
34. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Blanc PG; Gwira Baumblatt JA; Woo EJ; Gee J; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):249-254. PubMed ID: 35176008
[TBL] [Abstract][Full Text] [Related]
35. Behavioral Intention to Get a Booster Dose of COVID-19 Vaccine among Chinese Factory Workers.
Zhang K; Fang Y; Chan PS; Cao H; Chen H; Hu T; Chen Y; Zhou X; Wang Z
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564639
[TBL] [Abstract][Full Text] [Related]
36. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea.
Bae S; Lee YW; Lim SY; Lee JH; Lim JS; Lee S; Park S; Kim SK; Lim YJ; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH
J Korean Med Sci; 2021 May; 36(17):e115. PubMed ID: 33942579
[TBL] [Abstract][Full Text] [Related]
37. Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia.
Harapan H; Wagner AL; Yufika A; Winardi W; Anwar S; Gan AK; Setiawan AM; Rajamoorthy Y; Sofyan H; Vo TQ; Hadisoemarto PF; Müller R; Groneberg DA; Mudatsir M
Hum Vaccin Immunother; 2020 Dec; 16(12):3074-3080. PubMed ID: 32991230
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 specific antibody responses in healthcare workers after a third booster dose of CoronaVac or BNT162b2 vaccine.
Yavuz E; Günal Ö; Başbulut E; Şen A
J Med Virol; 2022 Aug; 94(8):3768-3775. PubMed ID: 35434796
[TBL] [Abstract][Full Text] [Related]
39. Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine.
Cucunawangsih C; Wijaya RS; Lugito NPH; Suriapranata I
Int J Infect Dis; 2022 May; 118():116-118. PubMed ID: 35192955
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of adverse reactions among individuals with three-dose COVID-19 vaccination.
Wang Y; Zhang Y; Zhang M; Zhang X; Li H; Wang Y; Wang W; Ji J; Wu L; Zheng D
J Infect Public Health; 2023 Jan; 16(1):125-132. PubMed ID: 36516647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
